#195 Understanding current practices for the management of advanced epithelial high-grade ovarian cancer in the UK: interim analysis from the OC-NOW survey (2023)

Christina Fotopoulou,Rebecca Bowen,Ranjit Manchanda,Agnieszka Michael,Stephen Mccormack,Allan Ullmann,Anthony Wesselbaum,Joe Eva,Rowan Miller

doi:10.1136/ijgc-2023-esgo.532

#195 Understanding current practices for the management of advanced epithelial high-grade ovarian cancer in the UK: interim analysis from the OC-NOW survey (2023)

Christina Fotopoulou, Rebecca Bowen + Show 7 more

Open Access

https://doi.org/10.1136/ijgc-2023-esgo.532

Copy DOI

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society	Publication Date: Sep 1, 2023
License type: other-oa

Affiliation: Imperial College London, Royal United Hospital Bath NHS Trust, Royal London Hospital, Queen Mary University of London, Royal Surrey NHS Foundation Trust, Middlesex University, Open Geospatial Consortium, University College London

#Consultancy Fees #Advanced Ovarian Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Introduction/BackgroundAdvanced high-grade ovarian cancer (OC) treatment has recently evolved to include novel targeted agents such as PARP-inhibitors (PARPi). ESMO/ESGO guidelines recommend biomarker testing to guide treatment decision-making. Our survey explores...

Full Text